90 related articles for article (PubMed ID: 12120006)
1. Treatment with 5-fluorouracil enhances radiosensitivity of the human pancreatic cancer cell line MiaPaCa-2.
Balart J; Capellà G; de los Inocentes RM; de Andrés J; Ares C; Craven-Bartle J; Lluís F
Pancreatology; 2002; 2(1):40-5. PubMed ID: 12120006
[TBL] [Abstract][Full Text] [Related]
2. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
[TBL] [Abstract][Full Text] [Related]
3. Influence of p53 status on radiation and 5-flourouracil synergy in pancreatic cancer cells.
Mohiuddin M; Chendil D; Dey S; Alcock RA; Regine W; Mohiuddin M; Ahmed MM
Anticancer Res; 2002; 22(2A):825-30. PubMed ID: 12014658
[TBL] [Abstract][Full Text] [Related]
4. Hydroxyurea and trimidox enhance the radiation effect in human pancreatic adenocarcinoma cells.
Leyden D; Ahmed N; Hassan HT
Anticancer Res; 2000; 20(1A):133-8. PubMed ID: 10769645
[TBL] [Abstract][Full Text] [Related]
5. Chemo-radio-gene therapy for colorectal cancer cells using Escherichia coli uracil phosphoribosyltransferase gene.
Koyama F; Fujii H; Mukogawa T; Ueno M; Hamada H; Ishikawa H; Doi S; Nakao T; Matsumoto H; Shimatani H; Takeuchi T; Nakajima Y
Anticancer Res; 2003; 23(2B):1343-8. PubMed ID: 12820392
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma.
Keene KS; Rich TA; Penberthy DR; Shepard RC; Adams R; Jones RS
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):97-103. PubMed ID: 15850908
[TBL] [Abstract][Full Text] [Related]
7. Drug efflux transporter multidrug resistance-associated protein 5 affects sensitivity of pancreatic cancer cell lines to the nucleoside anticancer drug 5-fluorouracil.
Nambaru PK; Hübner T; Köck K; Mews S; Grube M; Payen L; Guitton J; Sendler M; Jedlitschky G; Rimmbach C; Rosskopf D; Kowalczyk DW; Kroemer HK; Weiss FU; Mayerle J; Lerch MM; Ritter CA
Drug Metab Dispos; 2011 Jan; 39(1):132-9. PubMed ID: 20930123
[TBL] [Abstract][Full Text] [Related]
8. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma.
Furuse J; Kinoshita T; Kawashima M; Ishii H; Nagase M; Konishi M; Nakagohri T; Inoue K; Ogino T; Ikeda H; Maru Y; Yoshino M
Cancer; 2003 Mar; 97(5):1346-52. PubMed ID: 12599244
[TBL] [Abstract][Full Text] [Related]
10. A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer.
Wong JY; Shibata S; Williams LE; Kwok CS; Liu A; Chu DZ; Yamauchi DM; Wilczynski S; Ikle DN; Wu AM; Yazaki PJ; Shively JE; Doroshow JH; Raubitschek AA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5842-52. PubMed ID: 14676105
[TBL] [Abstract][Full Text] [Related]
11. Effect of an omega-3 fatty acid containing lipid emulsion alone and in combination with 5-fluorouracil (5-FU) on growth of the colon cancer cell line Caco-2.
Jordan A; Stein J
Eur J Nutr; 2003 Dec; 42(6):324-31. PubMed ID: 14673605
[TBL] [Abstract][Full Text] [Related]
12. Dual effects of folinic acid in 5-fluorouracil induced killing of human tumor cell lines in vitro.
Blomgren H; Edler D; Hallström M; Ragnhammar P
Anticancer Res; 1996; 16(5A):2713-7. PubMed ID: 8917376
[TBL] [Abstract][Full Text] [Related]
13. Dose escalation of concurrent hypofractionated radiotherapy and continuous infusion 5-FU-chemotherapy in advanced adenocarcinoma of the pancreas.
Zimmermann FB; Jeremic B; Lersch C; Geinitz H; Hennig M; Molls M
Hepatogastroenterology; 2005; 52(61):246-50. PubMed ID: 15783041
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of 5-fluorouracil radiosensitivity modulation in cultured mammalian cell lines.
Smalley SR; Kimler BF; Evans RG; Dalziel WC
Int J Radiat Oncol Biol Phys; 1992; 24(3):519-25. PubMed ID: 1399739
[TBL] [Abstract][Full Text] [Related]
15. 5-Fluorouracil modulation of radiosensitivity in cultured human carcinoma cells.
Smalley SR; Kimler BF; Evans RG
Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):207-11. PubMed ID: 1991680
[TBL] [Abstract][Full Text] [Related]
16. Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer.
Nita ME; Tominaga O; Nagawa H; Tsuruo T; Muto T
Hepatogastroenterology; 1998; 45(24):2117-22. PubMed ID: 9951876
[TBL] [Abstract][Full Text] [Related]
17. Biochemical modulation of combined radiation and 5-fluorouracil treatment of murine tumors by d,l-leucovorin.
Kovacs CJ; Dainer PM; Evans MJ; Nyce J
Anticancer Res; 1991; 11(2):905-9. PubMed ID: 2064349
[TBL] [Abstract][Full Text] [Related]
18. S-1, an oral fluoropyrimidine, enhances radiation response of DLD-1/FU human colon cancer xenografts resistant to 5-FU.
Nakata E; Fukushima M; Takai Y; Nemoto K; Ogawa Y; Nomiya T; Nakamura Y; Milas L; Yamada S
Oncol Rep; 2006 Sep; 16(3):465-71. PubMed ID: 16865244
[TBL] [Abstract][Full Text] [Related]
19. Modulation of 5-fluorouracil resistance in human colon tumor cell lines by azidothymidine.
Findenig G; Mader RM; Fritzer-Szekeres M; Steger GG; Jaeger W; Szekeres T
Oncol Res; 1996; 8(5):189-96. PubMed ID: 8884811
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the cytotoxic effect of 5-fluorouracil by N-methylformamide on a human colon carcinoma cell line.
Zupi G; Marangolo M; Arancia G; Greco C; Laudonio N; Iosi F; Formisano G; Malorni W
Cancer Res; 1988 Nov; 48(21):6193-200. PubMed ID: 3167866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
